| Mrs Margaret Smith-mindell, LCSW | |
|
569 Route 36, Belford, NJ 07718-1651 | |
| (732) 495-2350 | |
| (732) 495-2360 |
| Full Name | Mrs Margaret Smith-mindell |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 26 Years |
| Location | 569 Route 36, Belford, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548379050 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 44SC04858700 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lundrigan Counseling And Psychological Services Llc | 4981076668 | 2 |
News Archive
Kelyniam Global, Inc., an emerging medical device manufacturing company that recently was granted FDA 510(k) approval, announced today that it has begun commercial shipment of its Custom Skull Implants (CSI). Kelyniam CSI's are seen by many in the medical community as a game-changer in the world of medical prosthetics.
Despite the formula being recommended in public health guidelines set out by the Australasian Society of Clinical Immunology and Allergy, the new study, published online in the Journal of Allergy and Clinical Immunology, found there was no benefit in using hypoallergenic formula to prevent allergies in high-risk infants up to seven years of age, compared to a conventional cow's milk based formula.
A healthy lifestyle is especially important for young adult and teenage survivors of cancer, and how health behavior messages related to diet, exercise, smoking, and alcohol consumption are developed and presented may impact their effectiveness in this population.
A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity, a Mayo Clinic study has found. The findings indicate that Z-endoxifen, co-developed by Mayo Clinic Cancer Center and the National Cancer Institute, may provide a new and better treatment for some women with estrogen positive breast cancer and, in particular, for those women who do not respond to tamoxifen and aromatase inhibitors.
A new study by a team of researchers at the Welsh School of Pharmacy, Cardiff University, Wales, UK, has found that antimicrobial-containing wipes currently used to decontaminate surfaces in hospitals can spread pathogens after first use.
› Verified 2 days ago
| Entity Name | Halcyon Elder Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518076835 PECOS PAC ID: 9234169293 Enrollment ID: O20050824000245 |
News Archive
Kelyniam Global, Inc., an emerging medical device manufacturing company that recently was granted FDA 510(k) approval, announced today that it has begun commercial shipment of its Custom Skull Implants (CSI). Kelyniam CSI's are seen by many in the medical community as a game-changer in the world of medical prosthetics.
Despite the formula being recommended in public health guidelines set out by the Australasian Society of Clinical Immunology and Allergy, the new study, published online in the Journal of Allergy and Clinical Immunology, found there was no benefit in using hypoallergenic formula to prevent allergies in high-risk infants up to seven years of age, compared to a conventional cow's milk based formula.
A healthy lifestyle is especially important for young adult and teenage survivors of cancer, and how health behavior messages related to diet, exercise, smoking, and alcohol consumption are developed and presented may impact their effectiveness in this population.
A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity, a Mayo Clinic study has found. The findings indicate that Z-endoxifen, co-developed by Mayo Clinic Cancer Center and the National Cancer Institute, may provide a new and better treatment for some women with estrogen positive breast cancer and, in particular, for those women who do not respond to tamoxifen and aromatase inhibitors.
A new study by a team of researchers at the Welsh School of Pharmacy, Cardiff University, Wales, UK, has found that antimicrobial-containing wipes currently used to decontaminate surfaces in hospitals can spread pathogens after first use.
› Verified 2 days ago
| Entity Name | Caring People Nj Operating, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720514201 PECOS PAC ID: 7012324833 Enrollment ID: O20210323001991 |
News Archive
Kelyniam Global, Inc., an emerging medical device manufacturing company that recently was granted FDA 510(k) approval, announced today that it has begun commercial shipment of its Custom Skull Implants (CSI). Kelyniam CSI's are seen by many in the medical community as a game-changer in the world of medical prosthetics.
Despite the formula being recommended in public health guidelines set out by the Australasian Society of Clinical Immunology and Allergy, the new study, published online in the Journal of Allergy and Clinical Immunology, found there was no benefit in using hypoallergenic formula to prevent allergies in high-risk infants up to seven years of age, compared to a conventional cow's milk based formula.
A healthy lifestyle is especially important for young adult and teenage survivors of cancer, and how health behavior messages related to diet, exercise, smoking, and alcohol consumption are developed and presented may impact their effectiveness in this population.
A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity, a Mayo Clinic study has found. The findings indicate that Z-endoxifen, co-developed by Mayo Clinic Cancer Center and the National Cancer Institute, may provide a new and better treatment for some women with estrogen positive breast cancer and, in particular, for those women who do not respond to tamoxifen and aromatase inhibitors.
A new study by a team of researchers at the Welsh School of Pharmacy, Cardiff University, Wales, UK, has found that antimicrobial-containing wipes currently used to decontaminate surfaces in hospitals can spread pathogens after first use.
› Verified 2 days ago
| Entity Name | Lundrigan Counseling And Psychological Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932666807 PECOS PAC ID: 4981076668 Enrollment ID: O20230206001665 |
News Archive
Kelyniam Global, Inc., an emerging medical device manufacturing company that recently was granted FDA 510(k) approval, announced today that it has begun commercial shipment of its Custom Skull Implants (CSI). Kelyniam CSI's are seen by many in the medical community as a game-changer in the world of medical prosthetics.
Despite the formula being recommended in public health guidelines set out by the Australasian Society of Clinical Immunology and Allergy, the new study, published online in the Journal of Allergy and Clinical Immunology, found there was no benefit in using hypoallergenic formula to prevent allergies in high-risk infants up to seven years of age, compared to a conventional cow's milk based formula.
A healthy lifestyle is especially important for young adult and teenage survivors of cancer, and how health behavior messages related to diet, exercise, smoking, and alcohol consumption are developed and presented may impact their effectiveness in this population.
A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity, a Mayo Clinic study has found. The findings indicate that Z-endoxifen, co-developed by Mayo Clinic Cancer Center and the National Cancer Institute, may provide a new and better treatment for some women with estrogen positive breast cancer and, in particular, for those women who do not respond to tamoxifen and aromatase inhibitors.
A new study by a team of researchers at the Welsh School of Pharmacy, Cardiff University, Wales, UK, has found that antimicrobial-containing wipes currently used to decontaminate surfaces in hospitals can spread pathogens after first use.
› Verified 2 days ago
| Entity Name | Blue Sky Counseling & Wellness Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336921261 PECOS PAC ID: 1153772371 Enrollment ID: O20240111002515 |
News Archive
Kelyniam Global, Inc., an emerging medical device manufacturing company that recently was granted FDA 510(k) approval, announced today that it has begun commercial shipment of its Custom Skull Implants (CSI). Kelyniam CSI's are seen by many in the medical community as a game-changer in the world of medical prosthetics.
Despite the formula being recommended in public health guidelines set out by the Australasian Society of Clinical Immunology and Allergy, the new study, published online in the Journal of Allergy and Clinical Immunology, found there was no benefit in using hypoallergenic formula to prevent allergies in high-risk infants up to seven years of age, compared to a conventional cow's milk based formula.
A healthy lifestyle is especially important for young adult and teenage survivors of cancer, and how health behavior messages related to diet, exercise, smoking, and alcohol consumption are developed and presented may impact their effectiveness in this population.
A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity, a Mayo Clinic study has found. The findings indicate that Z-endoxifen, co-developed by Mayo Clinic Cancer Center and the National Cancer Institute, may provide a new and better treatment for some women with estrogen positive breast cancer and, in particular, for those women who do not respond to tamoxifen and aromatase inhibitors.
A new study by a team of researchers at the Welsh School of Pharmacy, Cardiff University, Wales, UK, has found that antimicrobial-containing wipes currently used to decontaminate surfaces in hospitals can spread pathogens after first use.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Margaret Smith-mindell, LCSW 569 Route 36, Belford, NJ 07718-1651 Ph: (732) 495-2350 | Mrs Margaret Smith-mindell, LCSW 569 Route 36, Belford, NJ 07718-1651 Ph: (732) 495-2350 |
News Archive
Kelyniam Global, Inc., an emerging medical device manufacturing company that recently was granted FDA 510(k) approval, announced today that it has begun commercial shipment of its Custom Skull Implants (CSI). Kelyniam CSI's are seen by many in the medical community as a game-changer in the world of medical prosthetics.
Despite the formula being recommended in public health guidelines set out by the Australasian Society of Clinical Immunology and Allergy, the new study, published online in the Journal of Allergy and Clinical Immunology, found there was no benefit in using hypoallergenic formula to prevent allergies in high-risk infants up to seven years of age, compared to a conventional cow's milk based formula.
A healthy lifestyle is especially important for young adult and teenage survivors of cancer, and how health behavior messages related to diet, exercise, smoking, and alcohol consumption are developed and presented may impact their effectiveness in this population.
A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity, a Mayo Clinic study has found. The findings indicate that Z-endoxifen, co-developed by Mayo Clinic Cancer Center and the National Cancer Institute, may provide a new and better treatment for some women with estrogen positive breast cancer and, in particular, for those women who do not respond to tamoxifen and aromatase inhibitors.
A new study by a team of researchers at the Welsh School of Pharmacy, Cardiff University, Wales, UK, has found that antimicrobial-containing wipes currently used to decontaminate surfaces in hospitals can spread pathogens after first use.
› Verified 2 days ago
Ms. Melisa Sheldon, L.C.S.W. Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 569 State Route 36, Belford, NJ 07718 Phone: 973-859-2700 | |
Amanda Arden Patterson, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: Halcyon Elder Care 569 Nj-36, Belford, NJ 07718 Phone: 732-495-2350 | |
Mr. Cameron A. Mazzeo, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 597 Turner Dr, Belford, NJ 07718 Phone: 609-495-9051 | |
Mrs. Gabrielle Vitaliano, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 67 Galloping Cir, Belford, NJ 07718 Phone: 908-514-8006 | |
Sandra Greenberg, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 569 Highway 36, Belford, NJ 07718 Phone: 732-495-2350 Fax: 732-495-2360 | |
Ms. Carol S. Walker, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 569 Highway 36, Belford, NJ 07718 Phone: 732-495-2350 Fax: 732-495-2367 |